2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Hemophilia A
1
Interventions
Cyclophosphamide
911
Carboplatin
788
pembrolizumab
749
Paclitaxel
745
Bevacizumab
717
Cisplatin
709
Gemcitabine
621
Docetaxel
585
Rituximab
559
Radiotherapy
548
Dexamethasone
512
Nivolumab
492
Doxorubicin
446
Fluorouracil
392
Capecitabine
382
Etoposide
358
Pemetrexed
339
Cytarabine
335
Oxaliplatin
335
Lenalidomide
328
Prednisone
328
Erlotinib Hydrochloride
323
fludarabine phosphate
316
Trastuzumab
305
Leucovorin
299
fludarabine
296
Vincristine
288
Bortezomib
284
Filgrastim
284
Cetuximab
277
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
recombinant FVIIa
×
Clear all
NCT02622321
2021-06-24
HAVEN 1
Hoffmann-La Roche
Phase 3
Completed
113 enrolled
45 charts
1 FDA